Annual ROE
-55.86%
-6.00%-12.03%
December 31, 2024
Summary
- As of March 1, 2025, RCKT annual return on equity is -55.86%, with the most recent change of -6.00% (-12.03%) on December 31, 2024.
- During the last 3 years, RCKT annual ROE has fallen by -18.68% (-50.24%).
- RCKT annual ROE is now -385.15% below its all-time high of 19.59%, reached on December 31, 2012.
Performance
RCKT ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-63.92%
-1.30%-2.08%
December 31, 2024
Summary
- As of March 1, 2025, RCKT quarterly return on equity is -63.92%, with the most recent change of -1.30% (-2.08%) on December 31, 2024.
- Over the past year, RCKT quarterly ROE has dropped by -12.09% (-23.33%).
- RCKT quarterly ROE is now -143.17% below its all-time high of 148.05%, reached on March 31, 2015.
Performance
RCKT Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RCKT ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.0% | -23.3% |
| 3 y3 years | -50.2% | -19.7% |
| 5 y5 years | -122.1% | -19.7% |
RCKT ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.2% | at low | -80.5% | at low |
| 5 y | 5-year | -122.1% | at low | -108.0% | at low |
| alltime | all time | -385.1% | +10.6% | -143.2% | +73.7% |
Rocket Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -55.86%(+12.0%) | -63.92%(+2.1%) |
| Sep 2024 | - | -62.62%(+15.0%) |
| Jun 2024 | - | -54.47%(+2.6%) |
| Mar 2024 | - | -53.10%(+2.5%) |
| Dec 2023 | -49.86%(+10.0%) | -51.83%(-2.9%) |
| Sep 2023 | - | -53.40%(-7.7%) |
| Jun 2023 | - | -57.83%(+3.8%) |
| Mar 2023 | - | -55.70%(+4.3%) |
| Dec 2022 | -45.31%(+21.9%) | -53.39%(+8.9%) |
| Sep 2022 | - | -49.01%(+11.5%) |
| Jun 2022 | - | -43.94%(+18.1%) |
| Mar 2022 | - | -37.21%(+5.1%) |
| Dec 2021 | -37.18%(+34.0%) | -35.41%(-6.6%) |
| Sep 2021 | - | -37.93%(-1.3%) |
| Jun 2021 | - | -38.42%(-7.7%) |
| Mar 2021 | - | -41.62%(-3.3%) |
| Dec 2020 | -27.74%(+10.3%) | -43.05%(+20.2%) |
| Sep 2020 | - | -35.81%(+10.0%) |
| Jun 2020 | - | -32.55%(+5.9%) |
| Mar 2020 | - | -30.73%(-4.1%) |
| Dec 2019 | -25.15% | -32.04%(-19.5%) |
| Sep 2019 | - | -39.80%(-6.9%) |
| Jun 2019 | - | -42.73%(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -46.81%(+4.4%) |
| Dec 2018 | -38.40%(-37.8%) | -44.83%(-8.9%) |
| Sep 2018 | - | -49.19%(-3.7%) |
| Jun 2018 | - | -51.08%(-0.6%) |
| Mar 2018 | - | -51.41%(-3.7%) |
| Dec 2017 | -61.76%(+5.4%) | -53.37%(+27.2%) |
| Sep 2017 | - | -41.96%(-2.8%) |
| Jun 2017 | - | -43.16%(-3.6%) |
| Mar 2017 | - | -44.76%(-7.8%) |
| Dec 2016 | -58.57%(-6.3%) | -48.57%(+24.0%) |
| Sep 2016 | - | -39.17%(-50.4%) |
| Jun 2016 | - | -78.94%(-8.2%) |
| Mar 2016 | - | -85.99%(-8.0%) |
| Dec 2015 | -62.48%(-437.9%) | -93.46%(-50.8%) |
| Sep 2015 | - | -189.78%(-21.9%) |
| Jun 2015 | - | -243.11%(-264.2%) |
| Mar 2015 | - | 148.05%(+302.9%) |
| Dec 2014 | 18.49%(-5.6%) | 36.75%(-23.0%) |
| Sep 2014 | - | 47.71%(+166.4%) |
| Jun 2014 | - | 17.91%(+69.1%) |
| Mar 2014 | - | 10.59%(+108.9%) |
| Dec 2013 | 19.58%(-0.1%) | 5.07% |
| Dec 2012 | 19.59% | - |
FAQ
- What is Rocket Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual ROE year-on-year change?
- What is Rocket Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly ROE year-on-year change?
What is Rocket Pharmaceuticals annual return on equity?
The current annual ROE of RCKT is -55.86%
What is the all time high annual ROE for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual return on equity is 19.59%
What is Rocket Pharmaceuticals annual ROE year-on-year change?
Over the past year, RCKT annual return on equity has changed by -6.00% (-12.03%)
What is Rocket Pharmaceuticals quarterly return on equity?
The current quarterly ROE of RCKT is -63.92%
What is the all time high quarterly ROE for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly return on equity is 148.05%
What is Rocket Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, RCKT quarterly return on equity has changed by -12.09% (-23.33%)